Influence of the AtlE autolysin on the activity of cell wall-active agents against Staphylococcus epidermidis.
Hello
Muriel
M
Caroff
Nathalie
N
Jacqueline
Cédric
C
Caillon
Jocelyne
J
Potel
Gilles
G
Batard
Eric
E
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy; D001426:Bacterial Proteins / Q000378:metabolism*; D002473:Cell Wall / Q000187:drug effects*; D003023:Cloxacillin / Q000494:pharmacology / Q000627:therapeutic use; D015169:Colony Count, Microbial; D051379:Mice; D050296:Microbial Viability / Q000187:drug effects; D009238:N-Acetylmuramoyl-L-alanine Amidase / Q000378:metabolism*; D010538:Peritonitis / Q000188:drug therapy; D013212:Staphylococcus epidermidis / Q000187:drug effects* / Q000378:metabolism*; D016019:Survival Analysis; D014640:Vancomycin / Q000494:pharmacology / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D014640:Vancomycin; D009238:N-Acetylmuramoyl-L-alanine Amidase; D003023:Cloxacillin